The SCOUT® wire-free radar localization system can help improve the surgical experience for breast cancer patients by eliminating the need to place a wire inside breast tissue to locate a tumor.
It can increase the probability of complete cancer removal while helping conserve healthy breast tissue during a lumpectomy or biopsy. SCOUT is FDA approved for long-term placement in breast and soft tissues.
SCOUT can help surgeons precisely target the affected tissue and pinpoint its location within 1 mm. This may contribute to more successful surgeries, optimized breast-conserving strategies, and improved outcomes for women.
How Does SCOUT Work?
Many women may require additional surgery after breast-conserving surgery because not all cancer cells may be removed during the initial procedure. SCOUT helps improve the likelihood of avoiding a second surgery.
Instead of using wires to localize breast tumors, SCOUT uses a tiny reflector smaller than a grain of rice, which is placed inside the tumor. This non-radioactive reflector acts as a guidance system for the surgeon and leads them directly to the tumor.
What Are the Benefits of SCOUT?
SCOUT eliminates the need for wire localization. It helps precisely identify the location and depth of the tumor and may require a shorter procedure time compared with wire localization.
By limiting the amount of tissue removed, SCOUT may contribute to better cosmetic results. Smaller incisions may be needed, which can support less pain and a quicker recovery. The reflector does not interfere with any medical imaging that may be required throughout the continuum of care.
When Should SCOUT Be Used?
Patients with early-stage breast cancer whose tumors cannot be felt by hand may be good candidates for SCOUT during a lumpectomy or excisional biopsy.
SCOUT can help surgeons locate the tumor more accurately during the first surgery. This may allow post-surgical treatments such as chemotherapy or radiation therapy to begin sooner.
